HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Optimal duration of treatment for acute hepatitis C in human immunodeficiency virus-positive individuals?

AuthorsGail V Matthews, Gregory J Dore
JournalHepatology (Baltimore, Md.) (Hepatology) Vol. 53 Issue 3 Pg. 1055-6; author reply 1056-7 (Mar 2011) ISSN: 1527-3350 [Electronic] United States
PMID21374672 (Publication Type: Letter, Comment)
Chemical References
  • Antiviral Agents
  • Interferon alpha-2
  • Interferon-alpha
  • Recombinant Proteins
  • Polyethylene Glycols
  • peginterferon alfa-2a
Topics
  • Adult
  • Antiviral Agents (administration & dosage)
  • HIV Infections (complications)
  • Hepatitis C (complications, drug therapy)
  • Humans
  • Interferon alpha-2
  • Interferon-alpha (administration & dosage)
  • Male
  • Polyethylene Glycols (administration & dosage)
  • Recombinant Proteins
  • Viral Load

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: